Business Opportunities

Wockhardt, Sun get US okay for generic drug

Indian drug companies Wockhardt and Sun Pharmaceutical Industries have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug. - Wockhardt ends weak despite US FDA nod for generic drug - Wockhardt gets FDA nod for Nicardipine injections - Not the right medicine - Caraco looking at shifting production to India - Wockhardt bleeds due to Rs 284-crore hit - Sun Pharma net profit dips 11.5% The approvals are to market generic versions of branded injection Cardene 25mg/10ml, marketed in the US by EKR Therapeutics. The patents covering this product had expired yesterday. According to drug sales tracking agency IMS, the total market for Nicardipine injection in the US is about $170 million. It is one of the few drugs that are used in injectable form to control hypertension in patients who are unable to receive oral medications. Global companies such as Teva Parenteral has approval for the same product. “The upside for Indian companies may be limited, as the market will be divided between 3 and 4 players. A clear picture will emerge in the coming days, as FDA may give more approvals,” said Ranjit Kapadia, vice-president, institutional equities, HDFC Securities. “This is our seventeenth sterile product approval in the US, based on a variety of technologies like liquid injections in vials and pre-filled syringes, powder for injection and ophthalmic solutions,” said Wockhardt Chairman Habil Khorakiwala.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
CV makers step on the gas after slump
As the world tries to get over the economic slump, commercial vehicle (CV) manufacturers like Tata Motors, Ashok Leyland, Eicher, Volvo, Daimler and Mahindra-Navistar are preparing for a flurry of launches to cash in on the increased economic activity in the country.
Popular Articles
quick payday loans

Letters: Sachin's best century
Sachin Tendulkar scored his best century on the day he completed 20 years in international cricket. By telling the Maharashtra Navnirman Sena (MNS) that he was an Indian first and a Maharashtrian later, Tendulkar has made several points. He has, of course, snubbed the MNS, but he has also told top professionals that they need to stand up and be counted. Just recently, Karan Johar apologised for calling Mumbai “Bombay” in a movie — while Johar and others fear the MNS will burn cinema halls showing their movies, Sachin has no such fear since the MNS can never hope to succeed in preventing fans from watching Sachin play. Interestingly, during the Mumbai riots, it was the original Little Master Sunil Gavaskar who used his stature in a similar manner to prevent mobs from killing Muslims.

Even if retired, keep some money in equity
I am a retired army pensioner and have deposited all my savings in bank fixed deposits. But I am losing a considerable amount on account of TDS, which the bank deducts on the interest payments. Currently, I want to invest Rs 1 lakh in some debt fund with a horizon period of one year. Please suggest some good mutual funds which can yield more income than bank fixed deposits and be tax friendly. Being retired, I cannot go for equity schemes.

© Copyright 2009